HB 1225

  • New Hampshire House Bill
  • 2024 Regular Session
  • Introduced in House Dec 01, 2023
  • House
  • Senate
  • Governor

relative to prescription drug affordability board conflicts of interest.

Votes


No votes to display

Actions


Oct 31, 2024

House

Interim Study Report: Not Recommended for Future Legislation (Vote 16-0)

Sep 25, 2024

House

Executive Session: 10/17/2024 10:00 am LOB 302-304

Aug 14, 2024

House

Full Committee Subcommittee Work Session: 09/12/2024 10:00 am LOB 302-304

Mar 28, 2024

House

Refer for Interim Study: MA VV 03/28/2024 HJ 10 P. 7

Mar 18, 2024

House

Committee Report: Refer for Interim Study 03/13/2024 (Vote 18-0; CC) HC 12 P. 6

Mar 07, 2024

House

Executive Session: 03/13/2024 10:00 am LOB 302-304

Feb 14, 2024

House

Subcommittee Work Session: 02/20/2024 10:00 am LOB 305

Feb 07, 2024

House

Subcommittee Work Session: 02/14/2024 10:00 am LOB 302-304

Jan 09, 2024

House

Public Hearing: 01/18/2024 10:15 am LOB 302-304

Dec 01, 2023

House

Introduced 01/03/2024 and referred to Commerce and Consumer Affairs

Bill Text

Bill Text Versions Format
latest version PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Hampshire General Court.

If you notice any inconsistencies with these official sources, feel free to file an issue.